108 related articles for article (PubMed ID: 24048798)
1. Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma.
Maresch J; Birner P; Zakharinov M; Toumangelova-Uzeir K; Natchev S; Guentchev M
Cancer; 2011 Jun; 117(11):2499-504. PubMed ID: 24048798
[TBL] [Abstract][Full Text] [Related]
2. Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: implications for clinical outcome.
Chatterjee D; Sabo E; Tavares R; Resnick MB
Clin Cancer Res; 2008 May; 14(10):2994-3001. PubMed ID: 18483365
[TBL] [Abstract][Full Text] [Related]
3. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
4. RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.
Cross-Knorr S; Lu S; Perez K; Guevara S; Brilliant K; Pisano C; Quesenberry PJ; Resnick MB; Chatterjee D
BMC Cancer; 2013 Oct; 13():463. PubMed ID: 24098947
[TBL] [Abstract][Full Text] [Related]
5. Raf kinase inhibitor protein (RKIP) in cancer.
Escara-Wilke J; Yeung K; Keller ET
Cancer Metastasis Rev; 2012 Dec; 31(3-4):615-20. PubMed ID: 22684368
[TBL] [Abstract][Full Text] [Related]
6. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin.
Gimenez M; Souza VC; Izumi C; Barbieri MR; Chammas R; Oba-Shinjo SM; Uno M; Marie SK; Rosa JC
Proteomics; 2010 Aug; 10(15):2812-21. PubMed ID: 20533335
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
Moon A; Park JY; Sung JY; Park YK; Kim YW
Pathology; 2012 Oct; 44(6):534-9. PubMed ID: 22935977
[TBL] [Abstract][Full Text] [Related]
9. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
Kim HS; Park SJ; Lee KY; Park YK; Kim YW
Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Raf kinase inhibitor protein and its significance in invasion and metastasis of hepatocellular carcinoma].
Wu XH; Wang SX; Yang YJ; Li JK; Xu Z; Tang RF
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):358-62. PubMed ID: 21875465
[TBL] [Abstract][Full Text] [Related]
12. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.
Haura EB; Zheng Z; Song L; Cantor A; Bepler G
Clin Cancer Res; 2005 Dec; 11(23):8288-94. PubMed ID: 16322287
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas.
Martinho O; Granja S; Jaraquemada T; Caeiro C; Miranda-Gonçalves V; Honavar M; Costa P; Damasceno M; Rosner MR; Lopes JM; Reis RM
PLoS One; 2012; 7(1):e30769. PubMed ID: 22292035
[TBL] [Abstract][Full Text] [Related]
15. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
[TBL] [Abstract][Full Text] [Related]
16. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
Fu Z; Kitagawa Y; Shen R; Shah R; Mehra R; Rhodes D; Keller PJ; Mizokami A; Dunn R; Chinnaiyan AM; Yao Z; Keller ET
Prostate; 2006 Feb; 66(3):248-56. PubMed ID: 16175585
[TBL] [Abstract][Full Text] [Related]
17. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
Hagan S; Al-Mulla F; Mallon E; Oien K; Ferrier R; Gusterson B; García JJ; Kolch W
Clin Cancer Res; 2005 Oct; 11(20):7392-7. PubMed ID: 16243812
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma.
Kim HS; Won KY; Kim GY; Kim SC; Park YK; Kim YW
Pathol Res Pract; 2012 May; 208(5):292-9. PubMed ID: 22464151
[TBL] [Abstract][Full Text] [Related]
19. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
Das G; Shiras A; Shanmuganandam K; Shastry P
Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
[TBL] [Abstract][Full Text] [Related]
20. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
